DeutschNewstral
Article
Mmarketwatch.com on 2016-12-19 23:28
Conatus shares skyrocket after Novartis license deal
Related news
Array BioPharma shares jump on Novartis cancer drug deal newsbizjournals.com- MEnergy Recovery shares skyrocket on Schlumberger licensing dealmarketwatch.com
- MPowerSecure shares skyrocket on Southern Co. acquisitionmarketwatch.com
- MQualcomm's stock surges after patent license deal in Chinamarketwatch.com
- MMedicines Co. shares jump 17% in premarket after report of potential Novartis offermarketwatch.com
- MFirst Citizens shares leap on SVB deal as Novartis stock boosted by breast-cancer drug trial1 min readmarketwatch.com
- MJuniper shares fall after Ericsson and Cisco dealmarketwatch.com
- MMattel, Hasbro shares jump after Bloomberg report of deal talksmarketwatch.com
- MYuma Energy shares up 5% after Permian Basin acreage dealmarketwatch.com
- MAerie Pharma shares skyrocket on glaucoma drug study resultsmarketwatch.com
- MBellerophon shares skyrocket on high blood pressure drug studymarketwatch.com
- MGNC shares skyrocket 10% after sales beatmarketwatch.com
- FNovartis cholesterol deal highlights mass-market opportunityft.com
- GSK, Novartis complete complex, multibillion-dollar dealbizjournals.com
CSL completes Novartis flu vaccine dealSydney Morning Herald- Longmont electric motor company makes Chinese deal; shares skyrocketbizjournals.com
- Trevena shares skyrocket on $40 million royalty-based financing dealbizjournals.com
- PAmgen shares drop as Novartis launches cheaper drugpacbiztimes.com
- MOshkosh shares soar after $6.7 billion military deal to replace humveesmarketwatch.com
- MCon-Way shares up 33% after $3 billion deal with XPO Logisticsmarketwatch.com